Moreover, in another study in a murine ovarian cancer model, dual antibody blockade or genetic knockout of LAG-3 and PD-1 resulted in enhanced CD8+ T-cell effector function and subsequent delayed tumor growth [92]. This evidence concerns the gene LAG3 and ovarian cancer.